Evolution Capital is a private equity firm investing in companies that have the ability to lead their market segments. Typically, Evolution Capital will invest $5 million to $20 million of equity capital in each of its transactions, targeting profitable businesses with up to $15.0 million in cash flow, gross margins in excess of 30%, and annual revenue and cash flow growth in excess of 10%. Evolution Capital is a generalist investor; however, the following industries are currently of interest: Service Providers to the Post-Secondary Education Industry; Healthcare Services; Pharmaceutical Services; Cosmetic Pharmaceuticals; Consumer Products; Business Process Outsourcing; Contract Packaging; Entertainment Related Products and Services; Targeted Marketing Services; and Disease Management.